ArticleCell death & disease2019

AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells.

Donghwa Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.